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Abstract
Background: Providing ongoing family centred support is an integral part of childhood cancer care. For
families living in regional and remote areas, opportunities to receive specialist support are limited by the
availability of health care professionals and accessibility, which is often reduced due to distance, time, cost
and transport. The primary aim of this work is to investigate the cost-effectiveness of videotelephony to
support regional and remote families returning home for the first time with a child newly diagnosed with
cancer
Methods/design: We will recruit 162 paediatric oncology patients and their families to a single centre
randomised controlled trial. Patients from regional and remote areas, classified by Accessibility/
Remoteness Index of Australia (ARIA+) greater than 0.2, will be randomised to a videotelephone support
intervention or a usual support control group. Metropolitan families (ARIA+ ≤ 0.2) will be recruited as an
additional usual support control group. Families allocated to the videotelephone support intervention will
have access to usual support plus education, communication, counselling and monitoring with specialist
multidisciplinary team members via a videotelephone service for a 12-week period following first discharge
home. Families in the usual support control group will receive standard care i.e., specialist multidisciplinary
team members provide support either face-to-face during inpatient stays, outpatient clinic visits or home
visits, or via telephone for families who live far away from the hospital. The primary outcome measure is
parental health related quality of life as measured using the Medical Outcome Survey (MOS) Short Form
SF-12 measured at baseline, 4 weeks, 8 weeks and 12 weeks. The secondary outcome measures are:
parental informational and emotional support; parental perceived stress, parent reported patient quality
of life and parent reported sibling quality of life, parental satisfaction with care, cost of providing improved
support, health care utilisation and financial burden for families.
Discussion: This investigation will establish the feasibility, acceptability and cost-effectiveness of using
videotelephony to improve the clinical and psychosocial support provided to regional and remote
paediatric oncology patients and their families.
Published: 5 March 2007
BMC Health Services Research 2007, 7:38 doi:10.1186/1472-6963-7-38
Received: 29 January 2007
Accepted: 5 March 2007
This article is available from: http://www.biomedcentral.com/1472-6963/7/38
© 2007 Bensink et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Health Services Research 2007, 7:38 http://www.biomedcentral.com/1472-6963/7/38
Page 2 of 8
(page number not for citation purposes)
Background
The Royal Children's Hospital (RCH) Haematology,
Oncology and Stem Cell Transplant Unit is the major ter-
tiary paediatric referral centre for Queensland, northern
New South Wales and the southwest Pacific. A multidisci-
plinary team of medical, nursing and allied health profes-
sionals provides care and support to children with cancer,
as well as their families. Each year the service cares for
around 100 newly diagnosed patients.
Childhood cancer presents a major life stressor for the
entire family [1,2]. Significant changes to the everyday
lives of families, practically, socially and emotionally,
cause major disruption [3-5]. There is evidence that this
disruption results in isolation and poor communication
between family members, anxiety, low self-esteem and
school problems for siblings [6] and anxiety, post-trau-
matic stress symptoms and risk of depression for parents
[7,8]. Families supporting home care of their child are
faced with personal and financial sacrifice, higher risk of
fatigue and burnout, and the prospect of managing signif-
icant symptomatology in their child. Their own mental
and emotional health is directly affected [9] as they expe-
rience high levels of depression and anxiety. Providing
ongoing support to these families is an essential part of
care [10-13].
Around 60% of the families cared for by the RCH (Figure
1) live in regional and remote areas (based on post code
and corresponding ARIA+ score – Accessibility/Remote-
ness Index of Australia [14,15]. For families living in
regional and remote areas, the opportunities to receive
specialist support are inhibited by a number of factors
[16] These include: availability of health care profession-
als [17] and accessibility due to distance, time, cost and
transport [18]. One possible solution is the use of online
support mechanisms, such as videotelephony, to help
give much needed support to patients, parents, siblings
and the family as a whole.
Studies investigating the use of videotelephony to date
have been mostly small scale projects focusing on feasibil-
ity. The potential of videotelephony in adult home nurs-
ing has been shown in pilot trials in the UK [19], the US
[20] and in Australia [21]. Low-quality compressed video
can be used to support care directly to the home. One
small study (n = 20) identified that whilst there are activ-
ities that cannot be conducted by videotelephone, those
that can coincide with the typical interactions occurring in
face-to-face home visits [22].
A larger scale exploratory investigation into the use of vid-
eotelephones for psychotherapy (n = 80) reported higher
scores for client levels of initiative, trust and spontaneity
via videotelephone than the same scores obtained for
face-to-face therapy [23]. Although this study did not
deliver services directly to patient homes (instead patients
were assessed via videotelephone between separate rooms
in the treating facility) it does provide evidence that vide-
otelephony can be used to provide the type of personal
psychosocial support required by paediatric oncology
patients and families. The most extensive study using vid-
eotelephones to support adult home care (n = 212) [24]
showed that:
• clinical and educational services can be delivered suc-
cessfully using videotelephones and the standard home
telephone network
• the quality of care delivered via virtual videotelephone
home visits was comparable to face-to-face home visits
with the added benefit of cost savings.
The only other evidence in the literature is in the area of
adult oncology. Videotelephones have been used success-
fully since 1998 to provide direct patient care and sup-
portive care [25], as well as supporting palliative care
delivery for patients in their home [26,27]. This has been
shown to be a cost-effective service delivery method [28].
Proportion of newly diagnosed paediatric oncology patients in major cities and regional and remote areas (data provided by the  Royal Children's Hospital January 2004 to January 2006, n = 180) Figure 1
Proportion of newly diagnosed paediatric oncology patients in major cities and regional and remote areas (data provided by the 
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A large randomised controlled trial in adult palliative care
is also underway in Canada [29]. To date there have been
no published studies investigating the use of videoteleph-
ony for supporting paediatric oncology families.
Hypotheses
1. Videotelephony will be a feasible and acceptable mode
of service delivery to regional and remote paediatric
oncology families
2. Support provided using videotelephony to regional and
remote paediatric oncology families will be as effective as
support provided via traditional mechanisms to metro-
politan families
3. Using videotelephony will be a cost-effective method of
service delivery.
Methods/design
Design
This study is a randomised controlled trial using three-
groups: (1) Regional and remote intervention group, (2)
Regional and remote control group, and (3) Metropolitan
control group. Families will be classified as either metro-
politan or regional and remote based on the ARIA+ score
using the post code of the family's primary place of resi-
dence. Regional and remote families will be randomly
allocated either to the intervention (1), or to a usual sup-
port control group (2). Metropolitan patients will receive
support via traditional means as an additional usual sup-
port control group (3). This group will be used to provide
a comparator against which the support provided to the
regional and remote families can be judged.
The protocol for this study is registered with the Australian
Clinical Trials Registry (ACTRN 012606000487516) and
has been approved by the Royal Children's Hospital and
Health Service District Ethics Committee and the Univer-
sity of Queensland Behavioural and Social Sciences Ethi-
cal Review Committee.
Participants
Patients of the Royal Children's Hospital Haematology,
Oncology and Stem Cell Transplant Unit will be identi-
fied by their paediatric oncologist before first discharge
home. To be included in the study patients will be: newly
diagnosed male or female paediatric oncology patients
aged 2–18 years. Patients will be excluded if a home tele-
phone connection of satisfactory quality cannot be
installed.
The paediatric oncology clinical nurse consultants respon-
sible for each patient will approach the family individu-
ally. Families will be asked to participate in a project
investigating the use of videotelephones for supporting
children with cancer and their families. A brief overview of
the project will be provided before each family is asked if
they consent to talk with a research assistant about the
project.
The research assistant responsible for the project will pro-
vide written information on the trial informing all poten-
tial participants about the study, the frequency, content
and expected duration of telephone interviews and what
their participation would entail before obtaining consent.
Randomization
An independent researcher with no direct involvement in
the trial will be responsible for random allocation. A table
of random numbers will be generated. Even numbers will
denote allocation of regional and remote participants to
the control group and odd numbers to the intervention
group. Allocations to either group based on the table of
random numbers will be written on a piece of paper and
sealed in sequentially numbered opaque envelopes. As
regional and remote families are enrolled in the trial, the
research assistant will obtain information on allocation
from the envelopes in sequential order and assign partici-
pants to their designated group. Due to the interactive
nature of the intervention it is not possible to blind clini-
cians providing the intervention or participants involved
in the study.
Interventions
Usual care
All patients regardless of location are conventionally sup-
ported at first discharge home by the specialist multidisci-
plinary team of medical, nursing and allied health
professionals. This is either done face-to-face during out-
patient clinic visits or during subsequent inpatient stays,
or via telephone to families who live far from the hospital.
Telephone calls between specialist team members and
families at home are used to assist with: problems that
arise, clinical assessment and management and to provide
education and counselling. Patients and families in the
usual support control groups (i.e., all metropolitan fami-
lies and those regional and remote families randomly
allocated to the regional and remote control group) will
have access to all of these standard services and facilities.
Videotelephone support
Patients randomly allocated to the regional and remote
intervention group will have access to all of the usual sup-
port plus the videotelephone service. The videotelephone
service can be used for: education, communication, coun-
selling and monitoring with specialist multidisciplinary
team members. The videotelephone service will be availa-
ble to families for a 12-week period following first dis-
charge home (families will be able to request a
videotelephone call with team members at any time, theBMC Health Services Research 2007, 7:38 http://www.biomedcentral.com/1472-6963/7/38
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oncology clinical nurse consultant will call the family
home twice a week for the first four weeks and weekly
thereafter using the standard telephone and will initiate
subsequent videotelephone calls with team members as
required). In addition, the videotelephone will be availa-
ble to family members to facilitate intra-family support
during inpatient stays.
Measurement
The SF-12v2 will be used to measure the primary outcome
measure, parental health related quality of life. The SF-12
is a valid and reliable measure [30,31] used in a number
of countries including Australia. More recently the SF-12
has been used in caregiver quality of life research [32].
Secondary outcome measures for parents will be: the
informational/emotional subscale of the Medical Out-
comes Study (MOS) Social Support Survey (a valid and
reliable instrument for quantifying social support [33]),
the 4-item Perceived Stress Scale (PSS) [34] and the FAM-
CARE scale (a valid and reliable instrument designed spe-
cifically to assess satisfaction with advanced cancer care
[35]). For patients and siblings the Pediatric Quality of
Life Inventory (Peds QL) parent proxy will be used (a
valid and reliable measure of quality of life in children
applicable to healthy populations and those with chronic
disease [36]). In addition the Health Utilities Index Mark
2 (HUI2) will be completed by parents and used to assess
patient quality-adjusted life years (QALYs).
Data collection will be undertaken via: user logs, chart
audits, service database reviews, telephone and in-person
interviews. Data collection with parents will begin at base-
line (after consent has been obtained). The interviewer
will be blinded to group allocation. Interviews will be
used to obtain: demographics, baseline SF-12 scores, base-
line informational and emotional support scores, base-
line patient and sibling quality of life scores, and baseline
satisfaction scores.
To reduce participant burden the completion of the vari-
ous interview components will be staggered (Table 1). The
initial interview will be the longest.
Data analysis
Sample size calculations
A total of 162 participants will be included in the study
(based on data provided by the tertiary paediatric oncol-
ogy referral centre this is feasible for a 24-month trial with
a 20% refusal/attrition rate), 108 in the control group –
54 metropolitan and 54 regional and remote, and 54 in
the regional and remote intervention group. Sample size
calculations are given for the two main comparisons and
economic analyses:
1. Regional and remote intervention group vs regional and
remote usual support control group
- To test whether the provision of videotelephones to fam-
ilies in regional and remote areas can improve the health
Table 1: Interview schedule.
Component Week
0123456789 1 0 1 1 1 2
Demographics
SF-12v2
Informational/emotional support
Perceived stress
Patient quality of life
Sibling quality of life
HUI2
Satisfaction
Health care utilisation
Family costs
9
9 9 9 9
9 9 9 9
9 9 9 9
9 9 9 9
9 9 9 9
9 9
9
9 9 9 9 9 9
9 9 9 9 9 9BMC Health Services Research 2007, 7:38 http://www.biomedcentral.com/1472-6963/7/38
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related quality of life of parents caring for a child with can-
cer over usual care, a unpaired t-test of the mean differ-
ence will be used [38]. This will be based on the SF-12 at
week 12.
- As no paediatric caregiver research using the SF-12v2 has
been undertaken in Australia to date, published evidenced
available on paediatric parental caregiver burden in the
US [39] and US norms [31] (Table 2) have been used as a
guide for the sample size calculation. A clinically impor-
tant difference would be to improve mean mental health
related quality of life of parents (SF-12 Mental Compo-
nent Summary [MCS]) in the intervention group by 7.5
points. This figure is further supported by calculation of
SF-12v2 standard error of measurement [SEM], calculated
as the standard deviation of an instrument multiplied by
the square root of one minus its reliability coefficient [40].
With an SD of 10 and reliability coefficient of 0.86 [31],
the MCS-12 has an SEM of 3.74. Evidence by Wywrich
[41] supports the use of one SEM as an approximation of
the minimal clinically important difference [MCID] of a
psychometric instrument. Using this approximation, an
improvement in MCS-12 of 7.5 represents two times the
MCID, which is a large clinically important difference.
- Based on an improvement in MCS-12 mean in the inter-
vention group of 7.5, and using SF-12v2 norm-based scor-
ing methods (US general population SF-12v2 mean of 50
and SD of 10 [31]), at a power of 90% and a two-sided sig-
nificance level of 1%, a sample size of 108 will be
required, i.e. 54 in the intervention group and 54 in the
control group.
2. Regional and remote intervention group vs metropolitan
usual support control group
- To test whether the provision of videotelephones to fam-
ilies in regional and remote areas can improve the mental
health related quality of life of parents to a level equiva-
lent to that of metropolitan families receiving usual sup-
port, a test of equivalence will be used (according to the
equivalence method described by Matthews [42]).
- With a two-sided significance level of 1%, sample size of
54, a mean difference between groups of zero and an
equivalence bound of plus/minus 7.5, the study has a
power of 87.2% for finding a genuine equivalence.
Statistical analysis
Data analysis will be on an intention-to-treat basis and
consist of univariate analysis between randomised groups
on the primary and secondary outcomes. A more in-depth
analysis will use longitudinal methods to account for cor-
relations within families and to examine changes over
time.
Economic analysis
It is hypothesised that using videotelephony will be a cost-
effective method of service delivery. Economic evaluation
will be investigated in four areas.
1. The cost of providing improved support
- The potential for videotelephony to improve the health
related quality of life of parents comes at a cost. The total
cost of providing the videotelephone service will be calcu-
lated including project establishment costs, equipment
costs, maintenance costs, communication costs and staff
costs.
2. Health care use savings
a. Use of local health services
- The improved support provided by videotelephony has
the potential to reduce the need for parents and patients
to access local health care services. These include (but are
not limited to) community nursing visits, general practi-
tioner consultations, psychosocial health care consulta-
tions, respite care, emergency room visits and local
hospital admissions. The improved support is not
intended to minimise the much needed and valued local
community support. Instead, the improved support pro-
vided by the videotelephone service reduces the need to
burden these services for reasons that can be avoided with
Table 2: Published evidence available on the SF-12 health-related quality of life instrument.
Context n Details Mean SD
The impact of paediatric tracheotomy on parental caregiver burden and health status (US)[39] 154 PCS-12
MCS-12
50.5
35.8
11.3 11.4
US Norms[31] 7069 General US population
PCS-12 49.63 9.91
MCS-12 49.37 9.75
Depression
PCS-12 45.55 11.71
MCS-12 37.40 10.76BMC Health Services Research 2007, 7:38 http://www.biomedcentral.com/1472-6963/7/38
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improved specialist support (i.e. improved symptom
management, improved continuity of care, improved psy-
chosocial support, improved care planning and improved
emergency management).
b. Use of the entire health system
- To investigate the effect on costs to the health system,
health care use data will be gathered. Information on
health care encounters (including in-patient, outpatient,
emergency department, general practitioner, home care
and respite care instances) will be collected from families
in the intervention and control groups with bi-weekly tel-
ephone interviews. Hand searching of patient medical
records will be completed to determine and verify all
health care encounters. Encounters will be valued accord-
ing to the Australian Medicare Benefits Schedule of
resource items and their associated costs.
3. Reduced financial burden for families
- Families may also benefit financially from the improved
support provided by the videotelephone service.
Improved support has the potential to reduce the need for
travel and associated costs. Information on family out-of-
pocket expenses (such as travel costs including fuel, park-
ing, fares; and other costs including meals, child care and
accommodation) will also be obtained to assess the direct
non-medical financial impact on families and how effec-
tively the videotelephone service reduces this impact.
4. Cost-effectiveness analysis
- The health system perspective will be used for the pri-
mary analysis, and will be augmented in subsequent anal-
ysis with direct non-medical costs. The costs of providing
the videotelephone service plus the total cost of health
service use for the intervention group will be compared to
the total cost of health service use identified in the
regional and remote usual support control group. This is
the incremental cost.
- Using the Research Instruments listed above, differences
between the intervention group and the regional and
remote usual support control group will be calculated.
From this, the incremental cost per additional unit of ben-
efit gained will be calculated, i.e. the incremental cost-
effectiveness ratio (ICER); e.g. it costs an additional $x to
improve parental quality of life by 1 point.
- A cost-utility analysis will also be undertaken. This
allows comparisons between programs to be made and
hence value for money judgements, as outcomes are
standardised into quality-adjusted life years (QALYs).
QALYs will be calculated using the HUI2 and the SF-6D
algorithm to convert the SF-12 scores into utility scores
(where 0 = dead, and 1.0 = best imaginable health state)
and multiplied by the duration of life in that health state
[37]. Differences in QALYs (for both parents and patients)
between groups will be used to estimate the incremental
cost-utility ratios.
- Sensitivity analyses will be conducted around the varia-
bles with the greatest uncertainty as well as the duration
of final utility score at the end of the 12-week follow-up.
Discussion
In 2001, over 600 children were diagnosed with cancer in
Australia [43]. By 2011, the incidence of childhood cancer
is projected to increase by 7% for females and 5% for
males [44]. The cumulative toll on these children and
their families is high, socially, psychologically and eco-
nomically. They have a greater risk of developing psycho-
logical and emotional difficulties than other children and
families [45]. The support provided by specialist health
professionals, the continuity of follow-up care and the
support provided by family members have been identified
as critical factors [46].
Improving the specialist support provided to these fami-
lies has the potential to increase the quality of life of the
entire family through: improved symptom identification
and management, the provision of information, educa-
tion and counselling, and better continuity of care. This
may also reduce the need for these families to access local
health care services for reasons that can be avoided with
improved specialist support. It also has the potential to
reduce some of the economic burden these families face
through reductions in unnecessary travel.
The use of videotelephony will overcome many of the
issues associated with providing improved support at a
distance including the availability of experienced special-
ist health care professionals in regional and remote areas,
and accessibility difficulties due to distance, time, cost
and transport.
This work will present a new and innovative use of video-
telephone technology as well as a new method for sup-
porting regional and remote oncology patients and their
families. The completion of a large randomised controlled
trial will add significantly to the small evidence base for
home telehealth [47]. It will be the first study of its kind
in paediatric oncology. With the inclusion of a compre-
hensive economic evaluation, it will set an international
benchmark as very few studies in home telehealth include
cost-effectiveness or cost utility analyses [48]. It will also
assist with the application of this model of support in
other health care contexts.BMC Health Services Research 2007, 7:38 http://www.biomedcentral.com/1472-6963/7/38
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